Tempus AI (NASDAQ:TEM) Research Coverage Started at Stifel Nicolaus

Stifel Nicolaus initiated coverage on shares of Tempus AI (NASDAQ:TEM) in a research report sent to investors on Tuesday morning, Marketbeat reports. The brokerage issued a buy rating and a $45.00 target price on the stock.

Other analysts also recently issued reports about the stock. TD Cowen began coverage on shares of Tempus AI in a research report on Tuesday. They issued a buy rating and a $50.00 target price on the stock. JPMorgan Chase & Co. initiated coverage on shares of Tempus AI in a research report on Tuesday. They set an overweight rating and a $42.00 price objective on the stock. Needham & Company LLC initiated coverage on shares of Tempus AI in a research note on Tuesday. They set a buy rating and a $47.00 price objective for the company. Finally, Loop Capital initiated coverage on shares of Tempus AI in a research note on Tuesday. They set a buy rating and a $48.00 price objective for the company. Nine analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock presently has a consensus rating of Buy and a consensus target price of $45.63.

Tempus AI Stock Up 7.1 %

NASDAQ:TEM opened at $37.50 on Tuesday. Tempus AI has a 1-year low of $22.89 and a 1-year high of $43.88.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.